High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: Use of marker genes to investigate hematopoietic reconstitution in adults

Human Gene Therapy

Volumn 7, Issue 5, 1996, Pages 669-684

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; GENE TRANSFER; HEMATOPOIESIS; HUMAN; LYMPHOMA; MARKER GENE; METASTASIS; PERIPHERAL BLOOD STEM CELL; STEM CELL TRANSPLANTATION;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; GENETIC MARKERS; GENETIC VECTORS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; TRANSDUCTION, GENETIC; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029916002     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.5-669     Document Type: Article

References (60)

1. Bosly A, Coiffier B, Gisselbrecht C et al: Bone Marrow Transplantation Prolongs Survival after Relapse in Aggressive-Lymphoma Patients Treated with the NHL-84 Regimen. J Clin Oncol 10:1615, 1992.
2. Clark G, Sledge GW, Osborne CK, et al: Survival from First Recurrence: Relative Importance of Prognostic Factors in 1,015 Breast Cancer Patients. J Clin Oncol 5:55, 1987.
3. Henderson IC: Chemotherapy for Advanced Disease, in Harris JR, Hellman S, Henderson IC, et al (eds): Breast Diseases, Philadelphia, PA, Lippincott, 1987, p 428.
4. Antman K, Ayash L, Elias A, et al: A Phase II Study of High-Dose Cyclophosphamide, Thiotepa, and Carboplatin with Autologous Marrow Support in Women with Measurable Advanced Breast Cancer Responding to Standard-Dose Therapy. J Clin Oncol 10:102, 1992.
5. Jones RB, Shpall EJ, Ross M, et al: AFM Induction Chemotherapy, Followed by Intensive Alkylating Agent Consolidation with Autologous Bone Marrow Support (ABMS) for Advanced Breast Cancer, Current Results. Proc Am Soc Clin Oncol 9:9, 1990. (abstr 30)
6. Williams S, Mick R, Dresser R, et al: High-Dose Consolidation Therapy with Autologous Stem-Cell Rescue in Stage IV Breast Cancer. J Clin Oncol 7:1824, 1989.
7. Peters WP, Ross M, Vredenburgh J, et al: High-Dose Chemotherapy and Autologous Bone Marrow Support as Consolidation After Standard-Dose Adjuvant Therapy for High-Risk Primary Breast Cancer. J Clin Onc 11:1132, 1993.
8. Gianni AM, Siena S, Bregni M, et al: Growth Factor-Supported High-Dose Sequential (HDS) Adjuvant Chemotherapy in Breast Cancer with ≥10 Positive Nodes. Proceedings ASCO 11:60, 1992.
9. Anderson WF, Human Gene Therapy 256:808, 1992.
10. Cornetta K, Tricot G, Braun ER, et al: Retroviral-Mediated Transfer of Bone Marrow Cells During Autologous Bone Marrow Transplantion for Acute Leukemia. Human Gene Therapy 3:305, 1992.
11. Sorrentino BP, Brandt SJ, Bodine D et al: Selection of Drug-Resistant Bone Marrow Cells in vivo after Retroviral Transfer of Human MDR1. Science 257:99, 1992.
12. Karlsson S: Treatment of Genetic Defects in Hematopoietic Cell Function by Gene Transfer. Blood 78:2481, 1991.
13. Rill DR, Holladay MS, Heslop HE et al: The Contribution of Autologous Marrow Infusion to the Restoration of Long-Term Hemopoiesis in Cancer Patients: A Study Using Gene Marking. Blood 82 (suppl): 86a, 1993.
14. Nolta JA, Kohn DB: Comparison of the Effects of Growth Factors on Retroviral Vector-Mediated Gene Transfer and the Proliferative Status of Human Hematopoietic Progenitor Cells. Human Gene Therapy 1:257, 1990.
15. Hughes PFD, Eaves CG, Oagge DE et al: High Efficiency Gene Transfer to Human Hematopoietic Cells Maintained in Long-Term Culture. Blood 74:1915, 1989.
16. Fink JK, Correll PH, Perri LK et al: Correction of Glucocerebrosidase Deficiency After Retroviral-Mediated Gene Transfer into Hematopoietic Progenitor Cells from Patients with Gaucher Disease. Proc Natl Acad Sci USA 87:2334, 1990.
17. Chervenick PA, Boggs DR: In Vitro Growth of Granulocytic and Monoclear Cell Colonies from Blood of Normal Individuals. Blood 37:131, 1971.
18. Bender JG, Unverzagt KL, Walker D et al: Identification and Comparison of CD34 Positive Cells and their Subpopulations from Normal Peripheral Blood and Bone Marrow Using Multicolor Flow Cytometry. Blood 77:2591, 1991.
19. Preti RA, Ahmed T, Ayello J et al: Hemopoietic Stem Cell Processing: Comparison of Progenitor Cell Recovery Using the Cobe 2991 Cell Washer and the Haemonetics V50 Apheresis System. Bone Marrow Transplantation 9:377, 1992.
20. Richman CM, Weiner RS, Yankee RA: Increase in Circulating Stem Cells Following Chemotherapy in Man. Blood 47:1031, 1976.
21. Socinski MA, Cannistra SA, Elias A et al: Granulocyte-Macrophage Colony Stimulating Factor Expands the Circulating Hematopoietic Progenitor Cell Compartment in Humans. Lancet 1:1194, 1988.
22. Gianni AM, Bregni M, Siena S et al: Rapid and Complete Hemopoietic Reconstitution Following Combined Transplantation of Autologous Blood and Marrow Cells. A Changing Role for High Dose Chemo-Radiotherapy. Hematol Oncol 7:139, 1989.
23. Gianni AM, Siena S, Bregni M et al: Granulocyte-Macrophage Colony Stimulating Factor to Harvest Circulating Hematopoietic Stem Cells for Autotransplantation. Lancet 2:580, 1989.
24. Siena S, Bregni M, Brando B et al: Circulation of CD34+ Hematopoietic Stem Cells in the Peripheral Blood of High-Dose Cyclophosphamide-Treated Patients: Enhancement by Intravenous Human Granulocyte-Macrophage Colony Stimulating Factor. Blood 74:1905, 1989.
25. Elias AD, Ayash L, Anderson KC et al: Mobilization of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Hematologic Support After High-Dose Intensification for Breast Cancer. Blood 79:3036, 1992.
26. Gribben JG, Freedman AS, Neuberg D et al: Immunologic Purging of Marrow Assessed by PCR Before Autologous Bone Marrow Transplantation for B-Cell Lymphoma. New Engl J of Med 325:1525, 1991.
27. Campana D, Coustan-Smith E, Jannossy G: The Immunological Detection of Minimal Residual Disease in Acute Leukemia. Blood 76:162, 1990.
28. Cote RJ, Rosen PP, Lesser ML et al: Prediction of Early Relapse in Patients with Operable Breast Cancer by Detection of Occult Bone Marrow Micrometastases. J Clin Oncol 9:1749, 1991.
29. Sharp JG, Kessinger A, Vaughan WP et al: Detection and Clinical Significance of Minimal Tumor Cell Contamination of Peripheral Stem Cell Harvests. Intern J Cell Cloning 10 (Supp 1):92, 1992.
30. Douer D, Chaiwun B, Glaspy J et al: Analysis of Peripheral Blood Progenitor Cell (PBPC) Harvests for Occult Breast Cancer Micrometastasis Using a Sensitive Immunohistochemical Method. J Clin Oncol 11, 55, 1993 (Abstract).
31. Cote R, Chaiwun B, Douer D et al: Detection of Occult Bone Marrow Micrometastases in Patients with Advanced Breast Cancer: Association with Site of Metastases and Disease Progression. J Clin Oncol 11, 13, 1993 (Abstract).
32. Sheridan WP, Begley CG, Christopher AJ et al: RM-Effect of Peripheral-Blood Progenitor Cells Mobilized by Filgrastim (G-CSF) on Platelet Recovery After High-Dose Chemotherapy. Lancet 3139:640, 1992.
33. Peters WP, Rosner G, Ross M et al: Comparative Effects of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) on Priming Peripheral Blood Progenitor Cells for Use with Autologous Bone Marrow After High-Dose Chemotherapy. Blood 81:1709, 1993.
34. Bregni M, Magni M, Siena S et al: Human Peripheral Blood Hematopoietic Progenitors are Optimal Targets of Retroviral-Mediated Gene Transfer. Blood 80:1918, 1992.
35. Kouides PA, Kaukelnen J, Abboud CN et al: The Potential Benefits of Mobilized Peripheral Blood Stem Cells (PBSC) in Autologous Bone Marrow Transplantation May be Offset by the Risks of PBSC Harvesting with Chemotherapy-CSF Mobilization. Blood 80 (Suppl 1), 235a, 1992.
36. Moss TJ, Sanders DG, Lasky LC et al: Contamination of Peripheral Blood Stem Cell Harvests by Circulating Neuroblastoma Cells. Blood 76:1879, 1990.
37. Negrin RS, Pesando J, Long GD et al: Comparison of Tumor Cell Contamination of "Purged" Bone Marrow to Peripheral Blood Mononuclear Cells Assessed by PCR in Non-Hodgkin's Lymphoma. Blood 80 (Suppl 1): 235a, 1992.
38. Smith C, Gasparetto C, Collins N et al: Purification and Partial Characterization of a Human Hematopoietic Precursor Population. Blood 77:2122, 1991.
39. Eaves CJ, Cashman JD, Eaves AC: Methodology of Long-Term Culture of Human Hemopoietic Cells. J Tiss Cult Meth 13:55, 1991.
40. Gordon MY, Healy LE, Craddock CF et al: Experimental Models for Peripheral Blood Stem Cell Autografting. Intern J Cell Cloning 10: (Suppl 1) 2, 1992.
41. Tepler I, Cannistra SA, Frei III E et al: Use of Peripheral-Blood Progenitor Cells Abrogates the Myelotoxicity of Repetitive Outpatient High-Dose Carboplatin and Cyclophosphamide Chemotherapy. J Clin Onc 11:1583, 1993.
42. Dick JE, Magli MC, Huszar D et al: Introduction of a Selectable Gene into Primitive Stem Cells Capable of Long-Term Reconstitution of the Hemopoietic System of W/Wv Mice. Cell 42:71, 1985.
43. Bodine DM, Karlsson S, Nienhuis AW: Combination of Interleukins 3 and 6 Preserves Stem Cell Function in Culture and Enhances Retrovirus-Mediated Gene Transfer into Hematopoietic Stem Cells. Proc Natl Acad Sci USA 86:8897, 1989.
44. Schuening FG, Kawahar K, Miller AD et al: Retrovirus-Mediated Gene Transduction into Long-Term Repopulating Marrow Cells of Dogs. Blood 78, 2568, 1991.
45. Wieder R, Cornetta K, Kessler SW, Anderson WF: Increased Efficiency of Retroviral-Mediated Gene Transfer and Expression in Primate Bone Marrow Progenitors After 5-Fluorouracil-Induced Hematopoietic Suppression and Recovery. Blood 77:498, 1991.
46. Siena S, Bregni M, Brando B et al: Flow Cytometry for Clinical Estimation of Circulating Hematopoietic Progenitors for Autologous Transplantation in Cancer Patients, Blood 77:400, 1991.
47. Tarella C, Ferrero D, Bregni M et al: Circulating Hemopoietic Precursors After High-Dose Cyclophosphamide and rhGM-CSF: Evidence for a Preferential Expansion of Early Progenitor Cells. Eur J Cancer 27:22, 1991.
48. Dunbar CE: Amendment to Clinical Research Project. Human Gene Ther 4:205, 1993.
49. Dunbar CE, O'Shaughnessy JA, Cottler-Fox M et al: Transplantation of Retrovirally-Marked CD34+ Bone Marrow and Peripheral Blood Cells in Patients with Multiple Myeloma or Breast Cancer. Blood 82 (Suppl 1) 217a, 1993.
50. Civin CI: Purified Progenitor/Stem Cells: Background, Feasibility, and Prospects for Clinical Transplantation. Intern J Cell Cloning 10 (Suppl 1): 16, 1992.
51. Berenson RJ, Andrews RG, Bensinger WI, et al: Antigen CD34+ Marrow Cells Engraft Lethally Irradiated Baboons. J Clin Invest 81:951, 1988.
52. Berenson RJ, Bensinger WI, Hill RS et al: Engraftment after Infusion of CD34+ Marrow Cells in Patients with Breast Cancer or Neuroblastoma. Blood 77:1717, 1991.
53. Shpall EJ, Jones RB, Franklin W et al: CD34 Positive (+) Marrow and/or Peripheral Blood Progenitor Cells (PBPCs) Provide Effective Hematopoietic Reconstitution of Breast Cancer Patients Following High-Dose Chemotherapy with Autologous Hematopoietic Progenitor Cell Support. Blood 80 (Suppl 1) 24a, 1992.
54. Brenner MK, Rill DR, Moen RC et al: Gene-Marking to Trace Origin of Relapse After Autologous Bone-Marrow Transplantation. Lancet 341:85, 1993.
55. Deisseroth A, Zu Z, Claxton D et al: Retroviral Marking Studies Show That Infused Exogenous Marrow Cells Give Rise to Hematopoietic Recovery After Autologous Transplant, and that Relapse After Autologous Transplant in CML may Arise from Ph+ Cells Present in Marrow at the Time of Transplant. Blood 82 (Suppl 1): 454, 1993.
56. Crooks GM, Kohn DB: Growth Factors Increase Amphotropic Retrovirus Binding to Human CD34+ Bone Marrow Progenitor Cells. Blood 82:3290, 1993.
57. Cassel A, Cottler-Fox M, Doren S, Dunbar CE: Retroviral Mediated Gene Transfer into CD34 enriched Human Peripheral Blood Stem Cells. Exp. Hematol 21:581, 1993.
58. Brenner M et al: Autologous Bone Marrow Transplant for Children with AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse. Human Gene Therapy 2:137, 1991.
59. Baum CM, Weissman IL, Tsukamoto AS et al: Isolation of a Candidate Human Hematopoietic Stem-Cell Population. Proc Natl Acad Sci USC 89:2803, 1992.
60. Brenner MK, Rill DR, Holladay MS et al: Gene marking to determine whether autologous marrow infusion restores long term hematopoiesis in cancer patients. Lancet 342:1134, 1993.